NEW YORK (GenomeWeb) – Organism design company Ginkgo Bioworks announced today that it has raised $100 million in a Series C funding round.

The firm said it plans to use the funds to grow into new markets such as commodity chemicals, industrial enzymes, and human health markets. It also plans to build a next-generation automated foundry called Bioworks2 where Ginkgo's organism engineers can develop new designs at a larger scale.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.